4-{[2-(2-CYCLOHEXEN-1-YL)ETHYL]AMINO}-1-BUTANOL
![]() |
- $60 - $353
- Product name: 4-{[2-(2-CYCLOHEXEN-1-YL)ETHYL]AMINO}-1-BUTANOL
- CAS: 923526-83-4
- MF: C12H23NO
- MW: 197.32
- EINECS:
- MDL Number:MFCD09055136
- Synonyms:4-{[2-(2-CYCLOHEXEN-1-YL)ETHYL]AMINO}-1-BUTANOL;1-Butanol, 4-[[2-(2-cyclohexen-1-yl)ethyl]amino]-;4-{[2-(cyclohex-2-en-1-yl)ethyl]amino}butan-1-ol
4 prices
Selected condition:
Brand
- Aronis compounds
- Matrix Scientific
- TRC
Package
- 10mg
- 500mg
- 1g
- 5g
- ManufacturerAronis compounds
- Product numberBBB/555
- Product description4-{[2-(2-cyclohexen-1-yl)ethyl]amino}-1-butanol
- Packaging5g
- Price$353
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number023837
- Product description4-{[2-(2-Cyclohexen-1-yl)ethyl]amino}-1-butanol
- Packaging500mg
- Price$199
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number023837
- Product description4-{[2-(2-Cyclohexen-1-yl)ethyl]amino}-1-butanol
- Packaging1g
- Price$306
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberC994550
- Product description4-{[2-(cyclohex-2-en-1-yl)ethyl]amino}butan-1-ol
- Packaging10mg
- Price$60
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Aronis compounds | BBB/555 | 4-{[2-(2-cyclohexen-1-yl)ethyl]amino}-1-butanol | 5g | $353 | 2021-12-16 | Buy |
Matrix Scientific | 023837 | 4-{[2-(2-Cyclohexen-1-yl)ethyl]amino}-1-butanol | 500mg | $199 | 2021-12-16 | Buy |
Matrix Scientific | 023837 | 4-{[2-(2-Cyclohexen-1-yl)ethyl]amino}-1-butanol | 1g | $306 | 2021-12-16 | Buy |
TRC | C994550 | 4-{[2-(cyclohex-2-en-1-yl)ethyl]amino}butan-1-ol | 10mg | $60 | 2021-12-16 | Buy |
Properties
Boiling point :307.5±25.0 °C(Predicted)
Density :0.941±0.06 g/cm3(Predicted)
pka :15.13±0.10(Predicted)
Density :0.941±0.06 g/cm3(Predicted)
pka :15.13±0.10(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|